期刊文献+

托烷司琼加镇静剂对减轻乳腺癌化疗所致恶心呕吐的效果评价 被引量:10

Efficacy of tropisetron and tranquilizer in reducing breast cancer chemotherapy- induced nauseaand vomiting
原文传递
导出
摘要 目的观察托烷司琼加镇静剂对预防乳腺癌化疗所致恶心呕吐的效果。方法将78例乳腺癌化疗患者随机分成单药组40例和复药组38例,单药组单用静脉滴注托烷司琼的止吐方法,复药组采用静脉滴注托烷司琼加肌肉注射氯丙嗪的止吐方法,观察2组恶心、呕吐发生情况d结果单药组恶心呕吐发生率显著高于复药组,2组不良反应发生率比较差异无统计学意义。结论静脉滴注托烷司琼加肌肉注射氯丙嗪的止吐方法可以减少乳腺癌化疗所致的恶心、呕吐,此方案值得推广。 Objective To observe the effect of tropisetron and tranquilizer on preventing nausea and vomiting induced by breast cancer chemotherapy, in comparison with using only tropisetron. Methods 78 cases of breast cancer patients undergoing chemotherapy were randomly divided into the observation group (40 cases) and the control group (38 cases). The observation group used the method of antiemetic intravenous tropisetron, while the control group adopted intravenous drip of tropisetron combined with intramuscular injection of chlorpremazine. The incidence of nausea and vomiting of two groups was observed. Results The incidence of nausea and vomiting of the observation group was higher than that of the control group. The incidence of adverse reaction showed no obvious difference between two groups. Conclusions Intravenous injection of tropisetron combined with intramuscular injection of chlorpromazine can reduce nausea and vomiting caused by chemotherapy of breast cancer, so this method is worthy of popularization.
出处 《中国实用护理杂志》 北大核心 2014年第3期54-55,共2页 Chinese Journal of Practical Nursing
关键词 托烷司琼 化疗 恶心 呕吐 预防 Tropisetron Chemotherapy Nausea Vomiting Preventions
  • 相关文献

参考文献4

二级参考文献38

  • 1邹燕梅,于世英.NCCN止吐临床指引(2005.1版)[J].循证医学,2006,6(1):54-64. 被引量:32
  • 2龙华.胃充盈度对化疗所致呕吐的影响[J].护士进修杂志,2006,21(6):507-508. 被引量:21
  • 3修元德.肿瘤化疗的止吐治疗[J].齐鲁医学杂志,2006,21(4):374-376. 被引量:21
  • 4杨之朋.心理护理对乳癌术后化疗病人情绪的影响[J].国际护理学杂志,2007,26(3):314-315. 被引量:13
  • 5金有豫.药理学[M].5版.北京:人民卫生出版社,2001:152-154.
  • 6Kearney N, Miller M, Maguire R, et al. WISECARE plus: Re- sults of a European study of a nursing intervention for the management of chemotherapy related symptoms[J]. Europe- an Journal of Oncology Nursing, 2008,12 (5) : 443- 448.
  • 7Ballatori E, Roila F, Ruggeri B, et al. The impact of chemother- apy-induced nausea and vomiting on health--related quality of life[J]. Supportive Care in Cancer, 2007,15 (2) : 179-185.
  • 8Miller M, Kearney N. Chemotherapy-related nausea and vom- king past reflections, present practice and future management [J]. Eur J Cancer Care, 2004,13 : 71 - 81.
  • 9Mei RF,Rhodes V,Bo X. The chinese translation of the index of nausea, vomiting, and retching[J]. Cancer Nursing, 2002,25 (2) : 134-140.
  • 10Chi TL, Nei MC, Hsueh EL, et al. Incidence of chemotherapy- induced nausea and vomiting in Taiwan: physicians and nurses estimation vs. patients reported outcomes[J]. Support Care Cancer, 2005, (13) :277--286.

共引文献55

同被引文献106

  • 1胡艳群,张军丽.腹腔镜下妇科手术护理150例分析[J].医学信息(医学与计算机应用),2014,0(16):264-264. 被引量:1
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 3陈艳,丁莉坤,孟玲燕,丁黎,杨林,文爱东.盐酸帕洛诺司琼注射液人体药动学研究[J].中国新药杂志,2007,16(10):806-809. 被引量:14
  • 4林远志,姜继锋.盐酸帕洛诺司琼与托烷司琼在恶性肿瘤化疗中止吐效果的临床观察.医学信息,2013,26(11):446-447.
  • 5Massabeau C, Filleron T, Wakil G, et al. The prognostic significance of lympho vascular invasion on biopsy specimens in lung cancer treatedwith definitive chemoradio therapy.Clin Lung Cancer, 2012,1(1): 59-67.
  • 6Kato H, Fukuchi M, Manda R, et al. Efficacy and toxicity of nedaplatinand 5-FU with radiation treatment of advanced esophageal arcinomas. Anticancer Res, 2003,23(4): 3493-3498.
  • 7Ingersoll G L, Wasilewski A, Hailerr M, et al. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study [J]. Oncol Nurs Forum, 2010, 37(2): 213-215.
  • 8Stoltz R, Cyong J C, Shah A, et al. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptmine-3 receptor antagonist, in US and Japanese health subjects [J]. J Clin Pharmacol, 2012, 44(5): 520-523.
  • 9Maemondo M, Masuda N, Sekine I, et al. A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy [J]. Ann Oncol, 2013, 20(11): 1860-1866.
  • 10Elsenberg P, Mackintosh F R, Rich P, et al. Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose- ranging clinical study [J]. Ann Oneol, 2013, 15(2): 330-337.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部